This compound is a sulfonamide derivative containing a pyrazole ring substituted with a trifluoromethyl group and a methylphenyl group. It is identified as an impurity associated with an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Celecoxib
pharmaceutical raw material
Aprepitant
pharmaceutical raw material
Ipamorelin
pharmaceutical raw material
Doxycycline monohydrate
pharmaceutical raw material
Roblitinib
pharmaceutical raw material
2,5-Dimethylcelecoxib
pharmaceutical raw material
Mavacoxib
pharmaceutical raw material
4-Desmethyl-2-methyl Celecoxib
pharmaceutical intermediate
4-[5-(3-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
MPVPOTMPKLOUHZ-UHFFFAOYSA-N
CC1=CC(=CC=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.